1. 1BA The impact of pathological factors on long-term local control in the EORTC boost no-boost trial. Issue 3 (September 2015) Authors: Vrieling, C.; Van Werkhoven, E.; Poortmans, P.; Struikmans, H.; Weltens, C.; Fourquet, A.; Jager, J.; Schinagl, D.; Collette, L.; Maingon, P.; Bartelink, H. Journal: European journal of cancer Issue: Volume 51:Issue 3(2015:Feb.) Page Start: S709 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Efficacy of CDK 4/6 inhibition after fulvestrant in metastatic breast cancer. (April 2018) Authors: Hoste, G.; Punie, K.; Wildiers, H.; Neven, P.; Vergote, I.; Beuselinck, B.; Concin, N.; Han, S.; Van Nieuwenhuysen, E.; Salihi, R.; Smeets, A.; Berteloot, P.; Lefever, I.; Nevelsteen, I.; Van Limbergen, E.; Weltens, C.; Janssen, H. Journal: European journal of cancer Issue: Volume 92(2018)Supplement 3 Page Start: S111 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. EP-1917: Comparison of Robustness Metrics in Intensity Modulated Proton Therapy. (April 2018) Authors: George, B.; Teoh, S.; Shukla, V.; Petillion, S.; Verhoeven, K.; Weltens, C.; Van den Heuvel, F. Journal: Radiotherapy and oncology Issue: Volume 127(2018)Supplement 1 Page Start: S1041 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. OC-0157: The impact of the boost technique on breast cancer recurrence in breast-conserving therapy. (April 2018) Authors: Kindts, I.; Verhoeven, K.; Laenen, A.; Janssen, H.; Van Limbergen, E.; Weltens, C. Journal: Radiotherapy and oncology Issue: Volume 127(2018)Supplement 1 Page Start: S80 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. OC-0505 Coverage with evidence development: generating real-life evidence on SBRT in Belgium. (May 2022) Authors: Lievens, Y.; Boesmans, L.; Engels, H.; Geets, X.; Jansen, N.; Janssens, S.; Lambrecht, M.; Remouchamps, V.; Roosens, S.; Stellamans, K.; Verellen, D.; Weltens, C.; Weytjens, R.; Van Damme, N. Journal: Radiotherapy and oncology Issue: Volume 170(2022)Supplement 1 Page Start: S454 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. OC-0597 Implementing a quality indicator project on a national basis: a feasibility study. (April 2019) Authors: Vaandering, A.; Lievens, Y.; Jansen, N.; Weltens, C.; Moretti, L.; Stellamans, K.; Vanhoutte, F.; Scalliet, P.; Remouchamps, V. Journal: Radiotherapy and oncology Issue: Volume 133(2019)Supplement 1 Page Start: S313 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. OC-0934 Outcomes of the EORTC 22922/10925 randomised trial according to the technique for nodal irradiation. (May 2022) Authors: Kaidar-Person, O.; Fortpied, C.; Hol, S.; Weltens, C.; Kirkove, C.; Budach, V.; Peignaux-Casasnovas, K.; van der Leij, F.; Vonk, E.; Valli, M.; Weidner, N.; Guckenberger, M.; Koiter, E.; Fourquet, A.; Bartelink, H.; Struikmans, H.; Poortmans, P. Journal: Radiotherapy and oncology Issue: Volume 170(2022)Supplement 1 Page Start: S824 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Omitting radiation therapy in women with triple-negative breast cancer leads to worse breast cancer-specific survival. (April 2017) Authors: Kindts, I.; Buelens, P.; Laenen, A.; Van Limbergen, E.; Janssen, H.; Wildiers, H.; Weltens, C. Journal: Breast Issue: Volume 32(2017) Page Start: 18 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Plasma markers showing differential baseline expression in relapsing versus non-relapsing patients with hormone sensitive breast tumors. (October 2020) Authors: Hatse, S.; Lambrechts, Y.; Punie, K.; Floris, G.; Berben, L.; Laenen, A.; Lambrechts, D.; Desmedt, C.; Weltens, C.; Smeets, A.; Van Ongeval, C.; Neven, P.; Wildiers, H. Journal: European journal of cancer Issue: Volume 138(2020)Supplement 1 Page Start: S73 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. PO-0650: Omitting radiotherapy in triple-negative breast cancer leads to worse cancer-specific survival. (May 2017) Authors: Kindts, I.; Buelens, P.; Laenen, A.; Van Limbergen, E.; Janssen, H.; Wildiers, H.; Weltens, C. Journal: Radiotherapy and oncology Issue: Volume 123:(2017:May)Supplement 1 Page Start: S339 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗